Mindfulness Meditation for Pulmonary Hypertension (MMPH) for Hypertension, Pulmonary

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
SUNY at Buffalo School of Nursing, Buffalo, NY
Hypertension, Pulmonary+1 More
Mindfulness Meditation for Pulmonary Hypertension (MMPH) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The MMPH program will include two Zoom-delivered sessions (Weeks #1 & #4), six video-recorded sessions (Weeks #2, #3, #5, #6, #7, #8), and daily mindfulness meditation practice using a mobile APP during an eight-week study period. Similar to the Urban Zen Integrative Therapy intervention, each MMPH session will include Gentle Body Movement (GBM,10-min), Restorative Pose (Pose,10-min), and Body Awareness Meditation (BAM, 20-min). Self-guided audio-video modules of various durations will be available according to participants' preference and level of comfort (5, 10, 20 minutes). The mobile-APP content will reinforce Zoom content such as mindful breathing, GBM of upper extremities, GBM of lower extremities, Pose sitting, Pose lying, and BAM practices. The MMPH content will be tailored to health management needs specific to PH with cultural consideration of mindfulness-related concepts (stress, responding to stress, resiliency).

Eligible Conditions

  • Hypertension, Pulmonary

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hypertension, Pulmonary

Study Objectives

3 Primary · 3 Secondary · Reporting Duration: Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, Week 8

Week 16
CAMS-R
Change is being assessed in EmPhasis-10
Change is being assessed in PHQ-9
Change is being assessed in Pulmonary Arterial Hypertension Symptom Scale (PAHSS)
Week 8
Pulmonary Hypertension- Specific Symptoms Pain, Anxiety, Fatigue, Dyspnea
Week 8
SUS-Modified MMPH

Trial Safety

Safety Progress

1 of 3

Other trials for Hypertension, Pulmonary

Trial Design

2 Treatment Groups

Comparison Arm or Waited List Arm
1 of 2
Treatment Arm
1 of 2
Active Control
Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: Mindfulness Meditation for Pulmonary Hypertension (MMPH) · No Placebo Group · N/A

Treatment Arm
Behavioral
Experimental Group · 1 Intervention: Mindfulness Meditation for Pulmonary Hypertension (MMPH) · Intervention Types: Behavioral
Comparison Arm or Waited List Arm
Behavioral
ActiveComparator Group · 1 Intervention: Mindfulness Meditation for Pulmonary Hypertension (MMPH) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8
Closest Location: SUNY at Buffalo School of Nursing · Buffalo, NY
Photo of new york 1Photo of new york 2Photo of new york 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Hypertension, Pulmonary
0 CompletedClinical Trials

Who is running the clinical trial?

State University of New York at BuffaloLead Sponsor
208 Previous Clinical Trials
44,220 Total Patients Enrolled
1 Trials studying Hypertension, Pulmonary
3 Patients Enrolled for Hypertension, Pulmonary
Tania Von VisgerPrincipal InvestigatorState University of New York at Buffalo School of Nursing

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You identify as a person of a different race than your own.
You are willing to participate in the mindfulness practice program for the duration of the study period.
You have access to a mobile phone.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.